PT  - JOURNAL ARTICLE
AU  - Konstantinoudis, Garyfallos
AU  - Cameletti, Michela
AU  - Gómez-Rubio, Virgilio
AU  - León Gómez, Inmaculada
AU  - Pirani, Monica
AU  - Baio, Gianluca
AU  - Larrauri, Amparo
AU  - Riou, Julien
AU  - Egger, Matthias
AU  - Vineis, Paolo
AU  - Blangiardo, Marta
TI  - Regional excess mortality during the 2020 COVID-19 pandemic: a study of five European countries
AID  - 10.1101/2021.10.18.21264686
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.10.18.21264686
4099  - http://medrxiv.org/content/early/2021/10/23/2021.10.18.21264686.short
4100  - http://medrxiv.org/content/early/2021/10/23/2021.10.18.21264686.full
AB  - The impact of the COVID-19 pandemic on excess mortality from all causes in 2020 varied across and within European countries. Using data for 2015-2019, we applied Bayesian spatio-temporal models to quantify the expected weekly deaths at the regional level had the pandemic not occurred in England, Greece, Italy, Spain, and Switzerland. With around 30%, Madrid, Castile-La Mancha, Castile-Leon (Spain) and Lombardia (Italy) were the regions with the highest excess mortality. In England, Greece and Switzerland, the regions most affected were Outer London and the West Midlands (England), Eastern, Western and Central Macedonia (Greece), and Ticino (Switzerland), with 15-20% excess mortality in 2020. Our study highlights the importance of the large transportation hubs for establishing community transmission in the first stages of the pandemic. Acting promptly to limit transmission around these hubs is essential to prevent spread to other regions and countries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementG.K. is supported by an MRC Skills Development Fellowship [MR/T025352/1]. M.B. is supported by a National Institutes of Health, grant number [R01HD092580-01A1]. Infrastructure support for this research was provided by the National Institute for Health Research Imperial Biomedical Research Centre (BRC). The work was partly supported by the MRC Centre for Environment and Health, which is funded by the Medical Research Council (MR/S019669/1, 2019-2024). V. Gomez-Rubio is supported by grant SBPLY/17/180501/000491, funded by Consejeria de Educacion, Cultura y Deportes (JCCM, Spain) and FEDER, and grant PID2019-106341GB-I00, funded by Ministerio de Ciencia e Innovacion (Spain). M.E. and J.R. are supported by by the Swiss National Science Foundation (grant 189498). The study uses Small Area Health Statistics (SAHSU) data, obtained from the Office for National Statistics. The work of the UK SAHSU Unit is overseen by Public Health England (PHE) and funded by PHE as part of the MRC-PHE Centre for Environment and Health also supported by the UK Medical Research Council, Grant number: MR/L01341X/1), and the National Institute for Health Research (NIHR) through its Health Protection Units (HPRUs) at Imperial College London in Environmental Exposures and Health and in Chemical and Radiation Threats and Hazards, and through Health Data Research UK (HDR UK). This paper does not necessarily reflect the views of Public Health England, the National Institute for Health Research or the Department of Health and Social Care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The analyses for England were covered by national research ethics approval from the London-South East Research Ethics Committee (Reference 17/LO/0846). Data access was covered by the Health Research Authority Confidentiality Advisory Group under section 251 of the National Health Service Act 2006 and the Health Service (Control of Patient Information) Regulations 2002 (Reference 20/CAG/0028). Data access for Greece was approved by the 28th Statistical Privacy Committee and the relevant letter of the president of the Hellenic Statistical Authority (ΓΠ-498/23-12-2020) in accordance with section 5.3 of the Minutes of the Statistical Privacy Committee. The study is about secondary, aggregate anonymised data so no additional ethical permission is required.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe provide at https://github.com/gkonstantinoudis/ExcessDeathsCOVID the final version of the datasets for Italy and Switzerland as their mortality data is available online.Raw mortality data files for Switzerland are provided at https://www.bfs.admin.ch/bfs/en/home/statistics/population/births-deaths/deaths.assetdetail.19184461.html and https://www.bfs.admin.ch/bfs/en/home/statistics/population/births-deaths/deaths.assetdetail.13187299.html, whereas for Italy at https://www.istat.it/it/archivio/240401. Access to mortality data for Greece, England and Spain is subject to requests. For England, the data were obtained from the Small Area Health Statistics Unit (SAHSU), which does not have permission to supply data to third parties. The data can be requested through the Office for National Statistics (https://www.ons.gov.uk/). For Greece, mortality data can be requested from ELSTAT (https://www.statistics.gr) and for Spain from the National Centre of Epidemiology at the Carlos III Health Institute (https://eng.isciii.es/eng.isciii.es/Paginas/Inicio.html).Population data is available at the following locations:England: https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/populationestimatesforukenglandandwalesscotlandandnorthernirelandGreece: The selected aggregation by age, sex and NUTS3 regions is subject to a request at: https://www.statistics.gr/en/statistical-data-requestItaly: http://demo.istat.it/ricostruzione/download.php?lingua=ita for 2015-2019 and http://demo. istat.it/popres/download.php?anno=2020&lingua=itafor2020Spain: https://www.ine.es/jaxiT3/Tabla.htm?t=9691Switzerland: https://www.pxweb.bfs.admin.ch/pxweb/en/px-x-0102010000_102/-/px-x-0102010000_102.px/